[1]
2026. Evaluation of Benzenesulfonamide Derivatives; Quinazoline and Sulfonamide Selectively Targeting Carbonic Anhydrase XII for Tumor Microenvironment Modulation in Human Breast Cancer Cells. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 5 (Jan. 2026), 893–904. DOI:https://doi.org/10.32947/ajps.v25i5.1306.